208 related articles for article (PubMed ID: 32839917)
1. Dexmedetomidine Provides Protection Against Hippocampal Neuron Apoptosis and Cognitive Impairment in Mice with Alzheimer's Disease by Mediating the miR-129/YAP1/JAG1 Axis.
Sun W; Zhao J; Li C
Mol Neurobiol; 2020 Dec; 57(12):5044-5055. PubMed ID: 32839917
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis.
Wang YL; Zhang Y; Cai DS
Mol Neurobiol; 2021 Oct; 58(10):5052-5066. PubMed ID: 34245441
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
Wang J; Wang Y
Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis.
Wang L; Liu W; Zhang Y; Hu Z; Guo H; Lv J; Du H
Mol Cell Biochem; 2020 Jun; 469(1-2):41-51. PubMed ID: 32323054
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer's disease via targeting the suppressor of zest 12.
Hu G; Shi Z; Shao W; Xu B
Brain Res Bull; 2022 Jan; 178():164-172. PubMed ID: 34715270
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine reduces propofol-induced hippocampal neuron injury by modulating the miR-377-5p/Arc pathway.
Chen Z; Ding Y; Zeng Y; Zhang XP; Chen JY
BMC Pharmacol Toxicol; 2022 Mar; 23(1):18. PubMed ID: 35337381
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of microRNA-196a improves cognitive impairment and alleviates neuronal damage in hippocampus tissues of Alzheimer's disease through downregulating LRIG3 expression.
Yang K; Feng S; Ren J; Zhou W
J Cell Biochem; 2019 Oct; 120(10):17811-17821. PubMed ID: 31119777
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K/Akt signaling pathway.
Xing N; Xing F; Li Y; Li P; Zhang J; Wang D; Zhang W; Yang J
Life Sci; 2020 Apr; 247():117359. PubMed ID: 32001264
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects rats from postoperative cognitive dysfunction via regulating the GABA
Zhu YS; Xiong YF; Luo FQ; Min J
Neuropathology; 2019 Feb; 39(1):30-38. PubMed ID: 30592096
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
Lian X; Zhang X; Chen W; Xue F; Wang G
Brain Res; 2024 Jan; 1822():148612. PubMed ID: 37778649
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer's disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model.
Duan Q; Si E
J Cell Biochem; 2019 Sep; 120(9):15891-15905. PubMed ID: 31144355
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine-up-regulated microRNA-381 exerts anti-inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4.
Fang H; Li HF; Yan JY; Yang M; Zhang JP
J Cell Mol Med; 2021 Feb; 25(4):2098-2109. PubMed ID: 33314611
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway.
Yi J; Chen B; Yao X; Lei Y; Ou F; Huang F
J Cell Biochem; 2019 Oct; 120(10):18053-18065. PubMed ID: 31190362
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
He B; Chen W; Zeng J; Tong W; Zheng P
J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
[TBL] [Abstract][Full Text] [Related]
15. microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1.
Fang H; Li HF; Yang M; Wang RR; Wang QY; Zheng PC; Zhang FX; Zhang JP
Biomed Pharmacother; 2019 May; 113():108671. PubMed ID: 30875657
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of mogrol against Aβ
Chen G; Liu C; Meng G; Zhang C; Chen F; Tang S; Hong H; Zhang C
J Pharm Pharmacol; 2019 May; 71(5):869-877. PubMed ID: 30585314
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a protects against pericyte apoptosis via directly targeting FOXO1: implication for ameliorated cognitive deficits in APP/PS1 mice.
Wu Q; Yuan X; Bai J; Han R; Li Z; Zhang H; Xiu R
Aging (Albany NY); 2019 Aug; 11(16):6120-6133. PubMed ID: 31467256
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment.
Lv X; Yan J; Jiang J; Zhou X; Lu Y; Jiang H
J Neurochem; 2017 Nov; 143(3):306-319. PubMed ID: 28881034
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Decline and Modulation of Alzheimer's Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons.
Barbato C; Giacovazzo G; Albiero F; Scardigli R; Scopa C; Ciotti MT; Strimpakos G; Coccurello R; Ruberti F
Mol Neurobiol; 2020 Jul; 57(7):3183-3194. PubMed ID: 32504417
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 and Acori Graminei Rhizoma Attenuates Neuron Cell Apoptosis by Promoting the Expression of miR-873-5p in Alzheimer's Disease.
Shi R; Zhang S; Cheng G; Yang X; Zhao N; Chen C
Neurochem Res; 2018 Aug; 43(8):1529-1538. PubMed ID: 29926354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
